Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
ObvioHealth a global digital clinical trials company announces a new strategic investment by Guardant Health Inc a leading precision oncology company offering liquid
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology cardiovascular and metabolic
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that dosing has recently begun in an integrated Phase I
Macquarie University researchers have identified a gene therapy that could help treat the eye disease glaucoma with potential applications for other neurodegenerative conditions such as Alzheimers disease Glaucoma may result in irreversible blindness...
Autobahn Therapeutics a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders today announced the closing of an oversubscribed
NanoViricides Inc a clinical stage global leader in broadspectrum antiviral nanomedicines today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that the FDA has accepted the BLA for BAT a proposed
IASO Biotechnology a biopharmaceutical company dedicated to discovering developing manufacturing and commercializing innovative cell therapy and antibody products announced that the investigational new drug application for the independently developed
Waters Corporation announced today the global release of the TA Instruments Rapid ScreeningDifferential Scanning Calorimeter designed for biopharmaceutical developers
Triastek Inc a global leader in D printing pharmaceuticals today announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE a next generation
